Get access

Co-delivery of Cell-permeable Chimeric Apoptosis AVPIR8 Peptide/p53 DNA for Cocktail Therapy

Authors

  • Huiyuan Wang,

    1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China
    Search for more papers by this author
  • Qianqian Guo,

    1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China
    Search for more papers by this author
  • Yifan Jiang,

    1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China
    Search for more papers by this author
  • Ergang Liu,

    1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China
    Search for more papers by this author
  • Yongxing Zhao,

    1. Zhengzhou University School of Pharmaceutical Sciences, Zhengzhou, 450001, China
    Search for more papers by this author
  • Huixin Wang,

    1. Zhengzhou University School of Pharmaceutical Sciences, Zhengzhou, 450001, China
    Search for more papers by this author
  • Yaping Li,

    Corresponding author
    1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China
    • Yaping Li, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China

      Yongzhuo Huang, The Key Laboratory of Smart Drug Delivery (Fudan University), MOE & PLA, Shanghai, 201203, China.

    Search for more papers by this author
  • Yongzhuo Huang

    Corresponding author
    1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China
    2. The Key Laboratory of Smart Drug Delivery (Fudan University), MOE & PLA, Shanghai, 201203, China
    • Yaping Li, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai, 201203, China

      Yongzhuo Huang, The Key Laboratory of Smart Drug Delivery (Fudan University), MOE & PLA, Shanghai, 201203, China.

    Search for more papers by this author

Abstract

The tetra-peptide AVPI, derived from the Smac/DIABLO N-terminal epitope, is able to trigger caspase activation and apoptotic process. However, its clinical value is greatly hampered by the nature of membrane-impermeability. Herein, the cell-penetrating chimeric apoptotic peptide of AVPIR8 is synthesized, of which the apoptosis-induced AVPI is strategically blended with the cell-penetrating sequence of octaarginine (R8). The dual-functionalized AVPIR8 is not only potent in inducing apoptosis in tumor cells due to the cell penetration ability, but also is able to work as gene carrier for transfering the tumor suppressor p53 DNA into cells, thus constructing a co-delivery drug system (AVPIR8/p53). Such system efficiently promotes apoptosis in cancer cells while sparing normal cells, and its antitumor activity is further significantly enhanced in combination with doxorubicin as cocktail therapy. More importantly, the anticancer efficacy of the cocktail is demonstrated to be able to arrest tumor growth in two animal tumor models (melanoma and cervical cancers), respectively. The chemotherapeutic dose in the AVPIR8/p53-based cocktail is significantly reduced by 80%, compared to the monotherapy of doxorubicin. The present results show the promise of the co-delivered AVPIR8/p53 as adjuvant therapy for boosting the conventional chemotherapeutics, with a unique benefit of enhanced productive treatment outcomes yet greatly reduced adverse toxicity.

Get access to the full text of this article

Ancillary